Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
110.3 USD | -1.49% | -0.32% | -10.28% |
May. 13 | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.28% | 7.06B | |
+31.37% | 588B | |
-2.88% | 364B | |
+19.90% | 326B | |
+5.16% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.78% | 167B | |
+0.47% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Insider Sell: Jazz Pharmaceuticals